Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrolyzed Lignin in Treatment of Helicobacter Pylori Infection
NCT07246681Phase 3Completed
- Sponsor
- Zagazig University
- Start
- Oct 2025
- Primary completion
- Aug 2026
- Modality
- Polymer-based Nanoparticles
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of lignin hydrolytic in Helicobacter pylori infection (2 arms), sponsored by Zagazig University. Primary endpoint: Helicobacter pylori Eradication Rate at 4 weeks. Started Oct 2025; status: completed.
02
Drugs
lignin hydrolytic
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT07246681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07246681.